Pfizer has terminated a Phase I trial of its investigational STING therapy in advanced solid tumors, according to an update ...
Facing declining valuations and funding challenges, public biotechs like bluebird bio are going private to restructure, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback